These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 4734119
1. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma. Pearson GR, Redmon LW, Bass LR. Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119 [No Abstract] [Full Text] [Related]
2. Effect of immune factors on the motility of lymphoma cells. Cochran AJ, Klein E, Keissling R. J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294 [No Abstract] [Full Text] [Related]
3. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system. Harada M, Pearson G, Redmon L, Winters E, Kasuga S. J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675 [Abstract] [Full Text] [Related]
4. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E. J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138 [Abstract] [Full Text] [Related]
9. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia. Ishimoto A, Ito Y. Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227 [No Abstract] [Full Text] [Related]
10. Serochemotherapy against a Moloney virus-induced leukemia. Pearson GR, Redmon LW, Pearson JW. Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564 [No Abstract] [Full Text] [Related]
11. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses. Ferrer JF. Int J Cancer; 1973 Sep 15; 12(2):378-88. PubMed ID: 4134124 [No Abstract] [Full Text] [Related]
13. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2. Ng AK, McIntire R, Holden HT, Herberman RB. J Immunol; 1978 Sep 15; 121(3):856-62. PubMed ID: 690439 [No Abstract] [Full Text] [Related]
14. Studies on the biological and antigenic properties of ESP-1 type C virus particles. Eckner RJ, Priori ES, Mirand EA, Dmochowski L. Cancer Res; 1974 Oct 15; 34(10):2521-9. PubMed ID: 4137948 [No Abstract] [Full Text] [Related]
16. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L. J Immunol; 1982 Feb 15; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
17. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors. Gorczynski RM, Knight RA. Eur J Immunol; 1975 Feb 15; 5(2):148-55. PubMed ID: 1086221 [Abstract] [Full Text] [Related]
18. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis. Plata F, Gomard E, Leclerc JC, Levy JP. J Immunol; 1973 Sep 15; 111(3):667-71. PubMed ID: 4542607 [No Abstract] [Full Text] [Related]